Metalloproteinases and Tissue Inhibitors in Generalized Myasthenia Gravis. A Preliminary Study

Introduction: Matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) have recently been proposed as promising biomarkers in different immune-mediated disorders. We evaluated the plasma levels of MMP-9 and MMP-2 and their tissue inhibitors TIMP-1 and TIMP-2 in a patients...

Popoln opis

Bibliografske podrobnosti
Main Authors: Vincenzo Di Stefano, Chiara Tubiolo, Andrea Gagliardo, Rosalia Lo Presti, Maria Montana, Massimiliano Todisco, Antonino Lupica, Gregorio Caimi, Cristina Tassorelli, Brigida Fierro, Filippo Brighina, Giuseppe Cosentino
Format: Article
Jezik:English
Izdano: MDPI AG 2022-10-01
Serija:Brain Sciences
Teme:
Online dostop:https://www.mdpi.com/2076-3425/12/11/1439
_version_ 1827647119602745344
author Vincenzo Di Stefano
Chiara Tubiolo
Andrea Gagliardo
Rosalia Lo Presti
Maria Montana
Massimiliano Todisco
Antonino Lupica
Gregorio Caimi
Cristina Tassorelli
Brigida Fierro
Filippo Brighina
Giuseppe Cosentino
author_facet Vincenzo Di Stefano
Chiara Tubiolo
Andrea Gagliardo
Rosalia Lo Presti
Maria Montana
Massimiliano Todisco
Antonino Lupica
Gregorio Caimi
Cristina Tassorelli
Brigida Fierro
Filippo Brighina
Giuseppe Cosentino
author_sort Vincenzo Di Stefano
collection DOAJ
description Introduction: Matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) have recently been proposed as promising biomarkers in different immune-mediated disorders. We evaluated the plasma levels of MMP-9 and MMP-2 and their tissue inhibitors TIMP-1 and TIMP-2 in a patients’ cohort with generalized myasthenia gravis (MG). Methods: Plasma concentrations of MMP-9, MMP-2, TIMP-1 and TIMP-2 were evaluated in 14 patients with generalized MG and 13 age- and sex-matched healthy controls. The severity of disease was assessed by the modified Osserman classification. Results: Compared to the healthy subjects, MG patients had increased plasma concentrations of MMP-9, but reduced plasma levels of MMP-2 and TIMP-1. MG patients also showed a positive correlation between MMP-2 concentrations and disease severity. An increase in MMP-9 levels and MMP-9/TIMP-1 ratio and a decrease in MMP-2 levels and MMP-2/TIMP-2 ratio were detected in patients with generalized MG. Higher levels of MMP-2 correlated with greater disease severity. Discussion: Our preliminary findings suggest that MMPs and TIMPs could play a role in the pathogenesis of MG and might be associated with the risk of clinical deterioration.
first_indexed 2024-03-09T19:14:46Z
format Article
id doaj.art-f95dba0fec894593b02cfdd5e5e7d3b8
institution Directory Open Access Journal
issn 2076-3425
language English
last_indexed 2024-03-09T19:14:46Z
publishDate 2022-10-01
publisher MDPI AG
record_format Article
series Brain Sciences
spelling doaj.art-f95dba0fec894593b02cfdd5e5e7d3b82023-11-24T03:55:58ZengMDPI AGBrain Sciences2076-34252022-10-011211143910.3390/brainsci12111439Metalloproteinases and Tissue Inhibitors in Generalized Myasthenia Gravis. A Preliminary StudyVincenzo Di Stefano0Chiara Tubiolo1Andrea Gagliardo2Rosalia Lo Presti3Maria Montana4Massimiliano Todisco5Antonino Lupica6Gregorio Caimi7Cristina Tassorelli8Brigida Fierro9Filippo Brighina10Giuseppe Cosentino11Department of Biomedicine, Neuroscience and Advanced Diagnostic (BIND), University of Palermo, 90127 Palermo, ItalyDepartment of Biomedicine, Neuroscience and Advanced Diagnostic (BIND), University of Palermo, 90127 Palermo, ItalyDepartment of Biomedicine, Neuroscience and Advanced Diagnostic (BIND), University of Palermo, 90127 Palermo, ItalyDepartment of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties, University of Palermo, 90127 Palermo, ItalyDepartment of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties, University of Palermo, 90127 Palermo, ItalyDepartment of Brain and Behavioral Sciences, University of Pavia, 27100 Pavia, ItalyDepartment of Biomedicine, Neuroscience and Advanced Diagnostic (BIND), University of Palermo, 90127 Palermo, ItalyDepartment of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties, University of Palermo, 90127 Palermo, ItalyDepartment of Brain and Behavioral Sciences, University of Pavia, 27100 Pavia, ItalyDepartment of Biomedicine, Neuroscience and Advanced Diagnostic (BIND), University of Palermo, 90127 Palermo, ItalyDepartment of Biomedicine, Neuroscience and Advanced Diagnostic (BIND), University of Palermo, 90127 Palermo, ItalyDepartment of Brain and Behavioral Sciences, University of Pavia, 27100 Pavia, ItalyIntroduction: Matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) have recently been proposed as promising biomarkers in different immune-mediated disorders. We evaluated the plasma levels of MMP-9 and MMP-2 and their tissue inhibitors TIMP-1 and TIMP-2 in a patients’ cohort with generalized myasthenia gravis (MG). Methods: Plasma concentrations of MMP-9, MMP-2, TIMP-1 and TIMP-2 were evaluated in 14 patients with generalized MG and 13 age- and sex-matched healthy controls. The severity of disease was assessed by the modified Osserman classification. Results: Compared to the healthy subjects, MG patients had increased plasma concentrations of MMP-9, but reduced plasma levels of MMP-2 and TIMP-1. MG patients also showed a positive correlation between MMP-2 concentrations and disease severity. An increase in MMP-9 levels and MMP-9/TIMP-1 ratio and a decrease in MMP-2 levels and MMP-2/TIMP-2 ratio were detected in patients with generalized MG. Higher levels of MMP-2 correlated with greater disease severity. Discussion: Our preliminary findings suggest that MMPs and TIMPs could play a role in the pathogenesis of MG and might be associated with the risk of clinical deterioration.https://www.mdpi.com/2076-3425/12/11/1439matrix metalloproteinasesanti-AChR antibodiesmyasthenia gravisneuromuscular junction
spellingShingle Vincenzo Di Stefano
Chiara Tubiolo
Andrea Gagliardo
Rosalia Lo Presti
Maria Montana
Massimiliano Todisco
Antonino Lupica
Gregorio Caimi
Cristina Tassorelli
Brigida Fierro
Filippo Brighina
Giuseppe Cosentino
Metalloproteinases and Tissue Inhibitors in Generalized Myasthenia Gravis. A Preliminary Study
Brain Sciences
matrix metalloproteinases
anti-AChR antibodies
myasthenia gravis
neuromuscular junction
title Metalloproteinases and Tissue Inhibitors in Generalized Myasthenia Gravis. A Preliminary Study
title_full Metalloproteinases and Tissue Inhibitors in Generalized Myasthenia Gravis. A Preliminary Study
title_fullStr Metalloproteinases and Tissue Inhibitors in Generalized Myasthenia Gravis. A Preliminary Study
title_full_unstemmed Metalloproteinases and Tissue Inhibitors in Generalized Myasthenia Gravis. A Preliminary Study
title_short Metalloproteinases and Tissue Inhibitors in Generalized Myasthenia Gravis. A Preliminary Study
title_sort metalloproteinases and tissue inhibitors in generalized myasthenia gravis a preliminary study
topic matrix metalloproteinases
anti-AChR antibodies
myasthenia gravis
neuromuscular junction
url https://www.mdpi.com/2076-3425/12/11/1439
work_keys_str_mv AT vincenzodistefano metalloproteinasesandtissueinhibitorsingeneralizedmyastheniagravisapreliminarystudy
AT chiaratubiolo metalloproteinasesandtissueinhibitorsingeneralizedmyastheniagravisapreliminarystudy
AT andreagagliardo metalloproteinasesandtissueinhibitorsingeneralizedmyastheniagravisapreliminarystudy
AT rosalialopresti metalloproteinasesandtissueinhibitorsingeneralizedmyastheniagravisapreliminarystudy
AT mariamontana metalloproteinasesandtissueinhibitorsingeneralizedmyastheniagravisapreliminarystudy
AT massimilianotodisco metalloproteinasesandtissueinhibitorsingeneralizedmyastheniagravisapreliminarystudy
AT antoninolupica metalloproteinasesandtissueinhibitorsingeneralizedmyastheniagravisapreliminarystudy
AT gregoriocaimi metalloproteinasesandtissueinhibitorsingeneralizedmyastheniagravisapreliminarystudy
AT cristinatassorelli metalloproteinasesandtissueinhibitorsingeneralizedmyastheniagravisapreliminarystudy
AT brigidafierro metalloproteinasesandtissueinhibitorsingeneralizedmyastheniagravisapreliminarystudy
AT filippobrighina metalloproteinasesandtissueinhibitorsingeneralizedmyastheniagravisapreliminarystudy
AT giuseppecosentino metalloproteinasesandtissueinhibitorsingeneralizedmyastheniagravisapreliminarystudy